289 related articles for article (PubMed ID: 18813353)
1. Clinical evaluation of M30 and M65 ELISA cell death assays as circulating biomarkers in a drug-sensitive tumor, testicular cancer.
de Haas EC; di Pietro A; Simpson KL; Meijer C; Suurmeijer AJ; Lancashire LJ; Cummings J; de Jong S; de Vries EG; Dive C; Gietema JA
Neoplasia; 2008 Oct; 10(10):1041-8. PubMed ID: 18813353
[TBL] [Abstract][Full Text] [Related]
2. Preclinical evaluation of M30 and M65 ELISAs as biomarkers of drug induced tumor cell death and antitumor activity.
Cummings J; Hodgkinson C; Odedra R; Sini P; Heaton SP; Mundt KE; Ward TH; Wilkinson RW; Growcott J; Hughes A; Dive C
Mol Cancer Ther; 2008 Mar; 7(3):455-63. PubMed ID: 18347133
[TBL] [Abstract][Full Text] [Related]
3. Serum cytokeratin 18 as a biomarker for gastric cancer.
Oyama K; Fushida S; Kinoshita J; Okamoto K; Makino I; Nakamura K; Hayashi H; Inokuchi M; Nakagawara H; Tajima H; Fujita H; Takamura H; Ninomiya I; Kitagawa H; Fujimura T; Ohta T
Clin Exp Med; 2013 Nov; 13(4):289-95. PubMed ID: 22825587
[TBL] [Abstract][Full Text] [Related]
4. Utilization of cytokeratin-based biomarkers for pharmacodynamic studies.
Linder S; Olofsson MH; Herrmann R; Ulukaya E
Expert Rev Mol Diagn; 2010 Apr; 10(3):353-9. PubMed ID: 20370591
[TBL] [Abstract][Full Text] [Related]
5. Elevated serum levels of M30 and M65 in patients with locally advanced head and neck tumors.
Ozturk B; Coskun U; Sancak B; Yaman E; Buyukberber S; Benekli M
Int Immunopharmacol; 2009 May; 9(5):645-8. PubMed ID: 19249390
[TBL] [Abstract][Full Text] [Related]
6. M30/M65 ratio predicts the outcome of paclitaxel chemotherapy for NSCLC.
Chu T; Jiang L; Ying W; Han B
Clin Transl Oncol; 2017 Mar; 19(3):326-331. PubMed ID: 27468866
[TBL] [Abstract][Full Text] [Related]
7. Method validation and preliminary qualification of pharmacodynamic biomarkers employed to evaluate the clinical efficacy of an antisense compound (AEG35156) targeted to the X-linked inhibitor of apoptosis protein XIAP.
Cummings J; Ranson M; Lacasse E; Ganganagari JR; St-Jean M; Jayson G; Durkin J; Dive C
Br J Cancer; 2006 Jul; 95(1):42-8. PubMed ID: 16804528
[TBL] [Abstract][Full Text] [Related]
8. Clinical significance of serum M30 and M65 levels in melanoma.
Tas F; Karabulut S; Serilmez M; Yildiz I; Sen F; Ciftci R; Duranyildiz D
Melanoma Res; 2013 Oct; 23(5):390-5. PubMed ID: 23812330
[TBL] [Abstract][Full Text] [Related]
9. The prognostic significance of the increase in the serum M30 and M65 values after chemotherapy and relationship between these values and clinicopathological factors in patients with advanced gastric cancer.
Bilici A; Ustaalioglu BB; Ercan S; Seker M; Yilmaz BE; Orcun A; Gumus M
Tumour Biol; 2012 Dec; 33(6):2201-8. PubMed ID: 22890829
[TBL] [Abstract][Full Text] [Related]
10. Qualification of M30 and M65 ELISAs as surrogate biomarkers of cell death: long term antigen stability in cancer patient plasma.
Cummings J; Ranson M; Butt F; Moore D; Dive C
Cancer Chemother Pharmacol; 2007 Nov; 60(6):921-4. PubMed ID: 17333190
[TBL] [Abstract][Full Text] [Related]
11. Prognostic value of M30/M65 for outcome of hepatitis B virus-related acute-on-chronic liver failure.
Zheng SJ; Liu S; Liu M; McCrae MA; Li JF; Han YP; Xu CH; Ren F; Chen Y; Duan ZP
World J Gastroenterol; 2014 Mar; 20(9):2403-11. PubMed ID: 24605039
[TBL] [Abstract][Full Text] [Related]
12. Usefulness of serum M30 and M65 levels to predict response to neoadjuvant chemotherapy in patients with breast cancer.
Turk HM; Aliyev A; Celik RS; Seker M; Coban E; Demir T; Baydas T; Kocyigit A
Curr Probl Cancer; 2020 Feb; 44(1):100497. PubMed ID: 31371034
[TBL] [Abstract][Full Text] [Related]
13. A high serum level of M65 is associated with tumour aggressiveness and an unfavourable prognosis for epithelial ovarian cancer.
Yildiz I; Tas F; Kilic L; Sen F; Saip P; Eralp Y; Keskin S; Karabulut S; Ciftci R; Serilmez M; Yasasever V; Aydiner A
Cancer Chemother Pharmacol; 2013 Aug; 72(2):437-44. PubMed ID: 23801282
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic value of serum M30 and M65 in patients with nasopharyngeal carcinoma.
Sen F; Yildiz I; Odabas H; Tambas M; Kilic L; Karadeniz A; Altun M; Ekenel M; Serilmez M; Duranyildiz D; Bavbek S; Basaran M
Tumour Biol; 2015 Feb; 36(2):1039-44. PubMed ID: 25326440
[TBL] [Abstract][Full Text] [Related]
15. Caspase-cleaved cytokeratin 18 fragment (M30) as marker of postoperative residual tumor load in colon cancer patients.
Ausch C; Buxhofer-Ausch V; Olszewski U; Hinterberger W; Ogris E; Schiessel R; Hamilton G
Eur J Surg Oncol; 2009 Nov; 35(11):1164-8. PubMed ID: 19254831
[TBL] [Abstract][Full Text] [Related]
16. Measuring soluble forms of extracellular cytokeratin 18 identifies both apoptotic and necrotic mechanisms of cell death produced by adenoviral-mediated interferon alpha: possible use as a surrogate marker.
Fisher MB; Zhang XQ; McConkey DJ; Benedict WF
Cancer Gene Ther; 2009 Jul; 16(7):567-72. PubMed ID: 19197325
[TBL] [Abstract][Full Text] [Related]
17. Cell Death and Prognosis of Mortality in Alcoholic Hepatitis Patients Using Plasma Keratin-18.
Woolbright BL; Bridges BW; Dunn W; Olson JC; Weinman SA; Jaeschke H
Gene Expr; 2017 Nov; 17(4):301-312. PubMed ID: 28770701
[TBL] [Abstract][Full Text] [Related]
18. Clinical significance of serum M30 and M65 levels in metastatic pancreatic adenocarcinoma.
Tas F; Karabulut S; Bilgin E; Sen F; Yildiz I; Tastekin D; Ciftci R; Duranyildiz D
Tumour Biol; 2013 Dec; 34(6):3529-36. PubMed ID: 23784459
[TBL] [Abstract][Full Text] [Related]
19. Is there any impact of plasma M30 and M65 levels on progression-free survival of patients with advanced gastric cancer?
Bilici A; Ustaalioglu BB; Ercan S; Orcun A; Seker M; Salepci T; Gumus M
Cancer Chemother Pharmacol; 2011 Aug; 68(2):309-16. PubMed ID: 20967544
[TBL] [Abstract][Full Text] [Related]
20. The prognostic importance of changing serum M30 and M65 values after chemotherapy in patients with advanced-stage non-small-cell lung cancer.
Ustaalioglu BB; Bilici A; Ercan S; Seker M; Orcun A; Gumus M
Med Oncol; 2013 Jun; 30(2):551. PubMed ID: 23536001
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
